These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36754259)

  • 1. Development of a population pharmacokinetic model and optimal dosing regimen of leflunomide in Korean population.
    Shin Y; Chae D; Park K
    Eur J Pharm Sci; 2023 May; 184():106402. PubMed ID: 36754259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A population pharmacokinetic study to accelerate early phase clinical development for a novel drug, teriflunomide sodium, to treat systemic lupus erythematosus.
    Yao X; Wu Y; Jiang J; Chen X; Liu D; Hu P
    Eur J Pharm Sci; 2019 Aug; 136():104942. PubMed ID: 31154006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and bioequivalence evaluation of leflunomide tablets in Korean healthy volunteers.
    Lim YJ; Shim EJ; Kim HS; Oh M; Shon JH; Shin JG; Moon BS; Song GS; Kim EY
    Drug Res (Stuttg); 2013 Dec; 63(12):633-8. PubMed ID: 23884659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precision Medicine With Leflunomide: Consideration of the DHODH Haplotype and Plasma Teriflunomide Concentration and Modification of Outcomes in Patients With Rheumatoid Arthritis.
    Wiese MD; Hopkins AM; King C; Wechalekar MD; Lee A; Spargo L; Metcalf R; McWilliams L; Hill C; Cleland LG; Proudman SM
    Arthritis Care Res (Hoboken); 2021 Jul; 73(7):983-989. PubMed ID: 32339392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics and association between A77 1726 plasma concentrations and disease activity measures following administration of leflunomide to people with rheumatoid arthritis.
    Chan V; Charles BG; Tett SE
    Br J Clin Pharmacol; 2005 Sep; 60(3):257-64. PubMed ID: 16120064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety, Pharmacokinetics, and Pharmacogenetics of Single-Dose Teriflunomide Sodium and Leflunomide in Healthy Chinese Subjects.
    Yao X; Wu Y; Jiang J; Hu P; Liu D; Chen X
    Clin Drug Investig; 2019 Jul; 39(7):643-651. PubMed ID: 31016613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A population pharmacokinetic model of methotrexate in Korean patients with haematologic malignancy.
    Jung YS; Son M; Lee SG; Chong JW; Kim SJ; Jang JE; Lyu CJ; Hahn SM; Han JW; Park K
    Br J Clin Pharmacol; 2024 Mar; 90(3):849-862. PubMed ID: 37984417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ABCG2 genotypes on the pharmacokinetics of A771726, an active metabolite of prodrug leflunomide, and association of A771726 exposure with serum uric acid level.
    Kim KA; Joo HJ; Park JY
    Eur J Clin Pharmacol; 2011 Feb; 67(2):129-34. PubMed ID: 20972558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population Pharmacokinetics of Teicoplanin in Preterm and Term Neonates: Is It Time for a New Dosing Regimen?
    Kontou A; Sarafidis K; Begou O; Gika HG; Tsiligiannis A; Ogungbenro K; Dokoumetzidis A; Agakidou E; Roilides E
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31932366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of leflunomide in Chinese healthy volunteers.
    Li J; Yao HW; Jin Y; Zhang YF; Li CY; Li YH; Xu SY
    Acta Pharmacol Sin; 2002 Jun; 23(6):551-5. PubMed ID: 12060531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of dosing regimen with WST11 by Monte Carlo simulations, using PK data collected after single IV administration in healthy subjects and population PK modeling.
    Fabre MA; Fuseau E; Ficheux H
    J Pharm Sci; 2007 Dec; 96(12):3444-56. PubMed ID: 17854075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leflunomide in dialysis patients with rheumatoid arthritis--a pharmacokinetic study.
    Bergner R; Peters L; Schmitt V; Löffler C
    Clin Rheumatol; 2013 Feb; 32(2):267-70. PubMed ID: 23179005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LC-MS/MS Method for the Quantification of the Leflunomide Metabolite, Teriflunomide, in Human Serum/Plasma.
    Rule GS; Rockwood AL; Johnson-Davis KL
    Methods Mol Biol; 2019; 1872():75-83. PubMed ID: 30350281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical delivery of leflunomide for rheumatoid arthritis treatment: evaluation of local tissue deposition of teriflunomide and its anti-inflammatory effects in an arthritis rat model.
    Bae J; Park JW
    Drug Dev Ind Pharm; 2016; 42(2):254-62. PubMed ID: 26006334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydroorotate dehydrogenase inhibitor A771726 (leflunomide) induces apoptosis and diminishes proliferation of multiple myeloma cells.
    Baumann P; Mandl-Weber S; Völkl A; Adam C; Bumeder I; Oduncu F; Schmidmaier R
    Mol Cancer Ther; 2009 Feb; 8(2):366-75. PubMed ID: 19174558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The active metabolite of leflunomide, A771726, inhibits both the generation of and the bone-resorbing activity of osteoclasts by acting directly on cells of the osteoclast lineage.
    Kobayashi Y; Ueyama S; Arai Y; Yoshida Y; Kaneda T; Sato T; Shin K; Kumegawa M; Hakeda Y
    J Bone Miner Metab; 2004; 22(4):318-28. PubMed ID: 15221489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A771726, the active metabolite of leflunomide, directly inhibits the activity of cyclo-oxygenase-2 in vitro and in vivo in a substrate-sensitive manner.
    Hamilton LC; Vojnovic I; Warner TD
    Br J Pharmacol; 1999 Aug; 127(7):1589-96. PubMed ID: 10455314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of hemodialysis on leflunomide plasma concentrations.
    Beaman JM; Hackett LP; Luxton G; Illett KF
    Ann Pharmacother; 2002 Jan; 36(1):75-7. PubMed ID: 11816264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetic and pharmacodynamic modeling of transformed binary effect data of triflusal in healthy Korean male volunteers: a randomized, open-label, multiple dose, crossover study.
    Park SM; Lee J; Seong SJ; Park JG; Gwon MR; Lim MS; Lee HW; Yoon YR; Yang DH; Kwon KI; Han S
    BMC Pharmacol Toxicol; 2014 Dec; 15():75. PubMed ID: 25534747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics and pharmacodynamics of ticagrelor and AR-C124910XX in Chinese healthy male subjects.
    Liu S; Xue L; Shi X; Sun Z; Zhu Z; Zhang X; Tian X
    Eur J Clin Pharmacol; 2018 Jun; 74(6):745-754. PubMed ID: 29442148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.